Unveiling new chapters in medullary thyroid carcinoma therapy: advances in molecular genetics and targeted treatment strategies

被引：1

作者：

Huai, Jia-Xuan ^{[1
,2
]}

Wang, Fang ^{[3
]}

Zhang, Wen-Hui ^{[1
,2
]}

Lou, Yan ^{[1
]}

Wang, Gao-Xiang ^{[1
]}

Huang, Li-Ji ^{[1
]}

Sun, Jing ^{[1
,2
]}

Zhou, Xi-Qiao ^{[1
,2
]}

机构：

[1] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Endocrinol, Affiliated Hosp, Nanjing, Peoples R China

[2] Nanjing Univ Chinese Med, Sch Clin Med 1, Nanjing, Peoples R China

[3] Xinyang Cent Hosp, Dept Otolaryngol, Xinyang, Peoples R China

来源：

FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷

基金：

中国国家自然科学基金;

关键词：

medullary thyroid carcinoma; molecular genetics; RET gene; RAS genes; targeted therapy; biomarkers; immunotherapy; multi-kinase inhibitors; RET PROTOONCOGENE; SOMATIC MUTATIONS; GROWTH-FACTOR; CANCER; EXPRESSION; ACTIVATION; OVEREXPRESSION; MANAGEMENT; RECEPTORS; PROFILES;

D O I：

10.3389/fendo.2024.1484815

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Medullary Thyroid Carcinoma (MTC), a neuroendocrine malignancy that arises from the calcitonin-secreting parafollicular C-cells of the thyroid, constitutes a minor yet impactful fraction of thyroid malignancies. Distinguished by its propensity for aggressive growth and a pronounced tendency for metastasis, MTC poses formidable obstacles to the early diagnosis and therapeutic intervention. The molecular genetics of MTC, particularly the role of the RET gene and the RAS gene family, have been extensively studied, offering insights into the pathogenesis of the disease and revealing potential therapeutic targets. This comprehensive review synthesizes the latest advancements in the molecular genetics of MTC, the evolution of precision therapies, and the identification of novel biomarkers. We also discuss the implications of these findings for clinical practice and the future direction of MTC research.

引用

页数：7

共 45 条

[31] Role of Molecular Targeted Therapeutic Drugs in Treatment of Oral Squamous Cell Carcinoma: Development and Current Strategies-A Review Article [J].

Singh, Himanshu ;

Patel, Vedant .

GLOBAL MEDICAL GENETICS, 2022, 09 (03) :242-246

[32] Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions [J].

Wang, Bo ;

Xiang, Yuchu ;

Liu, Xudong ;

Pan, Xiaoting ;

Peng, Lang ;

Ma, Jiajia .

FRONTIERS IN IMMUNOLOGY, 2025, 16

[33] Octreotide-Targeted Liposomes Loaded with CPT-11 Enhanced Cytotoxicity for the Treatment of Medullary Thyroid Carcinoma [J].

Iwase, Yuko ;

Maitani, Yoshie .

MOLECULAR PHARMACEUTICS, 2011, 8 (02) :330-337

[34] New perspectives on molecular targeted therapy in ovarian clear cell carcinoma [J].

Tan, D. S. P. ;

Miller, R. E. ;

Kaye, S. B. .

BRITISH JOURNAL OF CANCER, 2013, 108 (08) :1553-1559

[35] Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy [J].

Wang, Xiangyu ;

Wu, Jianlei ;

Xie, Wenli .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (08) :1055-1062

[36] Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy [J].

Kurzrock, R. ;

Atkins, J. ;

Wheler, J. ;

Fu, S. ;

Naing, A. ;

Busaidy, N. ;

Hong, D. ;

Sherman, S. .

ANNALS OF ONCOLOGY, 2013, 24 (09) :2256-2261

[37] Treatment of squamous cell carcinoma of the anal canal: A new strategies with anti-EGFR therapy and immunotherapy [J].

Gardini, A. Casadei ;

Passardi, A. ;

Fornaro, L. ;

Rosetti, P. ;

Valgiusti, M. ;

Ruscelli, S. ;

Monti, M. ;

Casadei, C. ;

Pagan, F. ;

Frassineti, G. L. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 123 :52-56

[38] Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study [J].

Sugimoto, Rie ;

Satoh, Takeaki ;

Ueda, Akihiro ;

Senju, Takeshi ;

Tanaka, Yuki ;

Yamashita, Shinsaku ;

Koyanagi, Toshimasa ;

Kurashige, Tomoyuki ;

Higuchi, Nobito ;

Nakamura, Tsukasa ;

Tanaka, Masatake ;

Azuma, Yuuki ;

Ohno, Akari ;

Ooho, Aritsune ;

Ooe, Mari ;

Mutsuki, Taiji ;

Uchimura, Koutarou ;

Kuniyoshi, Masami ;

Tada, Seiya ;

Aratake, Yoshifusa ;

Yoshimoto, Tsuyoshi ;

Yamashita, Naoki ;

Harada, Shigeru ;

Nakamuta, Makoto ;

Motomura, Kenta ;

Kohjima, Motoyuki .

MEDICINE, 2022, 101 (40) :E30871

[39] Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies [J].

Wang, Qiyue ;

Xin, Xiaofei ;

Dai, Qihao ;

Sun, Mengjuan ;

Chen, Jinhua ;

Mostafavi, Ebrahim ;

Shen, Yan ;

Li, Xueming .

PHARMACOLOGY & THERAPEUTICS, 2023, 250

[40] Anaplastic thyroid carcinoma: Expression profile of targets for therapy offers new insights for disease treatment [J].

Wiseman, Sam M. ;

Masoudi, Hamid ;

Niblock, Paddy ;

Turbin, Dmitry ;

Rajput, Ashish ;

Hay, John ;

Bugis, Samuel ;

Filipenko, Douglas ;

Huntsman, David ;

Gilks, Blake .

ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) :719-729

← 1 2 3 4 5 →